<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">medsovet</journal-id><journal-title-group><journal-title xml:lang="ru">Медицинский Совет</journal-title><trans-title-group xml:lang="en"><trans-title>Meditsinskiy sovet = Medical Council</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2079-701X</issn><issn pub-type="epub">2658-5790</issn><publisher><publisher-name>REMEDIUM GROUP Ltd.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.21518/ms2024-193</article-id><article-id custom-type="elpub" pub-id-type="custom">medsovet-8313</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ФУНКЦИОНАЛЬНЫЕ ЗАБОЛЕВАНИЯ ЖКТ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>FUNCTIONAL GASTROINTESTINAL DISEASES</subject></subj-group></article-categories><title-group><article-title>Распространенность и факторы риска функциональных абдоминальных расстройств по данным опросного исследования у молодежи</article-title><trans-title-group xml:lang="en"><trans-title>Prevalence and risk factors of functional abdominal disorders according to a survey study among young people</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-6505-1031</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Жесткова</surname><given-names>Т. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Zhestkova</surname><given-names>T. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Жесткова Татьяна Васильевна, к.м.н., доцент, доцент кафедры пропедевтики внутренних болезней, </p><p>390026, Рязань, ул. Высоковольтная, д. 9</p></bio><bio xml:lang="en"><p>Tatyana V. Zhestkova, Cand. Sci. (Med.), Associate Professor of the Department of Propaedeutic Internal Diseases, </p><p>9, Vysokovoltnaya St., Ryazan, 390026</p></bio><email xlink:type="simple">t-zhestkova@bk.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Рязанский государственный медицинский университет имени академика И.П. Павлова</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Ryazan State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2024</year></pub-date><pub-date pub-type="epub"><day>04</day><month>06</month><year>2024</year></pub-date><volume>0</volume><issue>8</issue><fpage>12</fpage><lpage>18</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Жесткова Т.В., 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="ru">Жесткова Т.В.</copyright-holder><copyright-holder xml:lang="en">Zhestkova T.V.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.med-sovet.pro/jour/article/view/8313">https://www.med-sovet.pro/jour/article/view/8313</self-uri><abstract><sec><title>Введение</title><p>Введение. Этиологические аспекты функциональной диспепсии (ФД) и синдрома раздраженного кишечника (СРК) не ясны, эпидемиология заболеваний в возрастных группах и социумах может помочь в понимании стартовых причин патологии.</p></sec><sec><title>Цель</title><p>Цель. Оценить факторы риска развития и распространенность абдоминальных симптомов, характерных для ФД и СРК, среди активных пользователей интернет-сообществ.</p></sec><sec><title>Материалы и методы</title><p>Материалы и методы. Проведен анонимный онлайн-опрос среди студентов медицинского университета. Анкета содержала вопросы о характерных для ФД и СРК жалобах за последнюю неделю, «тревожных» симптомах, личностных характеристиках респондента и возможных факторах риска: курение, семейный анамнез, прием антибиотиков, препаратов железа, нестероидных противовоспалительных средств (НПВС).</p></sec><sec><title>Результаты</title><p>Результаты. В исследование включено 983 респондента в возрасте 18−26 лет, 279 мужчин и 704 женщины. Симптомы неисследованных регулярных (&gt;1 раза в нед.) постпрандиальных диспепсических расстройств, вздутия живота и абдоминальной боли выявлены у 391 (39,8%) человека, из них 29% мужчин и 44% женщин (p &lt; 0,001). Факторами риска для регулярных неисследованных расстройств было наличие родственников с хроническими заболеваниями желудочно-кишечного тракта (ОШ 2,05 [1,56; 2,70]), женский пол (ОШ 1,92 [1,43; 2,59]), прием НПВС (ОШ 1,48 [1,14; 1,91]), для женщин − курение (ОШ 2,24 [1,57; 3,18]). Критериям ФД соответствовало 6,5% респондентов, из них с изолированной эпигастральной болью − 23,4%, изолированным постпрандиальным дистресс-синдромом – 26,6%, сочетанным вариантом ФД − 50% чело век. Критериям СРК соответствовало 2,5% респондентов, из которых у 64% был overlap-синдром с ФД. Наличие ФД было связано с приемом НПВС: r = 0,081; p = 0,011 (ОШ 1,95 [1,16; 3,30]).</p></sec><sec><title>Выводы</title><p>Выводы. Распространенность ФД и/или СРК среди лиц 18−26 лет составляет 7,4% без достоверных различий среди мужчин и женщин. Прием НПВС может рассматриваться как фактор, способствующий развитию ФД.</p></sec></abstract><trans-abstract xml:lang="en"><sec><title>Introduction</title><p>Introduction. The etiological aspects of functional dyspepsia (FD) and irritable bowel syndrome (IBS) are not clear; the epidemiology of diseases in age groups and societies can help in understanding the starting causes of the pathology.</p></sec><sec><title>Aim</title><p>Aim. To assess the risk factors for the development and prevalence of abdominal symptoms characteristic of FD and IBS among active users of Internet communities.</p></sec><sec><title>Materials and methods</title><p>Materials and methods. An anonymous online survey was conducted among medical university students. The questionnaire contains questions about complaints typical of FD and IBS over the past week, “alarm” symptoms, personal characteristics of the respondent and possible risk factors: smoking, family history, taking antibiotics, iron pills, non-steroidal anti-inflammatory drugs (NSAIDs).</p></sec><sec><title>Results and discussion</title><p>Results and discussion. The study included 983 respondents aged 18−26 years, 279 men and 704 women. Symptoms of unstudied regular (&gt;1 time per week) postprandial dyspeptic disorders, bloating and abdominal pain were identified in 391 (39.8%) people, of which 29% were men and 44% were women (p &lt; 0.001). Risk factors for regular unstudied disorders were having relatives with chronic gastrointestinal diseases (OR 2.05 [1.56, 2.70]); female gender (OR 1.92 [1.43, 2.59]); taking NSAIDs (OR 1.48 [1.14; 1.91]); for women – smoking (OR 2.24 [1.57; 3.18]). 6.5% of respondents met the criteria for FD, of which 23.4% had isolated epigastric pain, 26.6% had isolated postprandial distress syndrome, and 50% had combined FD. 2.5% of respondents met the criteria for IBS, 64% of whom had overlap syndrome with FD. The presence of FD was associated with NSAIDs use: r = 0.081; p = 0.011 (OR 1.95 [1.16; 3.30]).</p></sec><sec><title>Conclusions</title><p>Conclusions. The prevalence of FD and/or IBS among people aged 18−26 years is 7.4%, with no significant differences between men and women. Taking NSAIDs can be considered as a factor contributing to the development of FD.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>синдром раздраженного кишечника</kwd><kwd>функциональная диспепсия</kwd><kwd>абдоминальная боль</kwd><kwd>функциональные заболевания</kwd><kwd>факторы риска</kwd></kwd-group><kwd-group xml:lang="en"><kwd>irritable bowel syndrome</kwd><kwd>functional dyspepsia</kwd><kwd>abdominal pain</kwd><kwd>functional diseases</kwd><kwd>risk factors</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин ВТ, Маев ИВ, Шелыгин ЮА, Баранская ЕК, Белоус СС, Белоусова ЕА и др. Диагностика и лечение синдрома раздраженного кишечника (Клинические рекомендации Российской гастроэнтерологической ассоциации и Ассоциации колопроктологов России). Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2021;31(5):74–95. https://doi.org/10.22416/1382-4376-2021-31-5-74-95.</mixed-citation><mixed-citation xml:lang="en">Ivashkin VT, Maev IV, Shelygin YuA, Baranskaya EK, Belous SS, Belousova EA et al. Diagnosis and treatment of irritable bowel syndrome: clinical recommendations of the Russian gastroenterological association and association of coloproctologists of Russia. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2021;31(5):74–95. (In Russ.) https://doi.org/10.22416/1382-4376-2021-31-5-74-95.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин ВТ, Маев ИВ, Шептулин АА, Лапина ТЛ, Трухманов АС, Картавенко ИМ и др. Клинические рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению функциональной диспепсии. Российский журнал гастроэнтерологии, гепатологии, колопроктологии . 2017;27(1):50–61. https://doi.org/10.22416/1382-4376-2017-27-1-50-61.</mixed-citation><mixed-citation xml:lang="en">Ivashkin VT, Mayev IV, Sheptulin AA, Lapina TL, Trukhmanov AS, Kartavenko IM et al. Diagnosis and treatment of the functional dyspepsia: clinical guidelines of the Russian Gastroenterological Association. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2017;27(1):50–61. (In Russ.) https://doi.org/10.22416/1382-4376-2017-27-1-50-61.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021;160(1):99–114.e3. https://doi.org/10.1053/j.gastro.2020.04.014.</mixed-citation><mixed-citation xml:lang="en">Sperber AD, Bangdiwala SI, Drossman DA, Ghoshal UC, Simren M, Tack J et al. Worldwide Prevalence and Burden of Functional Gastrointestinal Disorders, Results of Rome Foundation Global Study. Gastroenterology. 2021;160(1):99–114.e3. https://doi.org/10.1053/j.gastro.2020.04.014.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Лазебник ЛБ, Голованова ЕВ, Волель БА, Корочанская НВ, Лялюкова ЕА, Мокшина МВ и др. Функциональные заболевания органов пищеварения. Синдромы перекреста. Клинические рекомендации Российского Научного Медицинского Общества Терапевтов и Научного Общества Гастроэнтерологов России. Экспериментальная и клиническая гастроэнтерология. 2021;192(8):5–117. https://doi.org/10.31146/1682-8658-ecg-192-8-5-117.</mixed-citation><mixed-citation xml:lang="en">Lazebnik LB, Golovanova EV, Volel BA, Korochanskaya NV, Lyalyukova EA, Mokshina MV et al. Functional gastrointestinal disorders. Overlap syndrome. Clinical guidelines of the Russian Scientific Medical Society of Internal Medicine and Gastroenterological Scientific Society of Russia. Experimental and Clinical Gastroenterology. 2021;192(8):5–117. (In Russ.) https://doi.org/10.31146/1682-8658-ecg-192-8-5-117.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol. 2020;17(8):473–486. https://doi.org/10.1038/s41575-020-0286-8.</mixed-citation><mixed-citation xml:lang="en">Black CJ, Ford AC. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol. 2020;17(8):473–486. https://doi.org/10.1038/s41575-020-0286-8.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Burns GL, Hoedt EC, Walker MM, Talley NJ, Keely S. Physiological mechanisms of unexplained (functional) gastrointestinal disorders. J Physiol. 2021;599(23):5141–5161. https://doi.org/10.1113/JP281620.</mixed-citation><mixed-citation xml:lang="en">Burns GL, Hoedt EC, Walker MM, Talley NJ, Keely S. Physiological mechanisms of unexplained (functional) gastrointestinal disorders. J Physiol. 2021;599(23):5141–5161. https://doi.org/10.1113/JP281620.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Kumagai H, Yokoyama K, Imagawa T, Yamagata T. Functional dyspepsia and irritable bowel syndrome in teenagers: Internet survey. Pediatr Int. 2016;58(8):714–720. https://doi.org/10.1111/ped.12884.</mixed-citation><mixed-citation xml:lang="en">Kumagai H, Yokoyama K, Imagawa T, Yamagata T. Functional dyspepsia and irritable bowel syndrome in teenagers: Internet survey. Pediatr Int. 2016;58(8):714–720. https://doi.org/10.1111/ped.12884.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Корнеенков АА, Овчинников ПА, Вяземская ЕЭ, Дворянчиков ВВ, Рязанцев СВ, Янов ЮК, Фанта ИВ. Оценка условий труда и риски, обусловленные пандемией COVID-19: результаты онлайн-опроса персонала медицинских организаций. Медицинский совет. 2023;17(7):160–169. https://doi.org/10.21518/ms2023-071.</mixed-citation><mixed-citation xml:lang="en">Korneenkov AA, Ovchinnikov PA, Vyazemskaya EE, Dvoryanchikov VV, Ryazantsev SV, Yanov YuK, Fanta IV. Assessment of working conditions and risks caused by the COVID-19 pandemic: results of an online survey of personnel of medical organizations. Meditsinskiy Sovet. 2023;17(7):160–169. (In Russ.) https://doi.org/10.21518/ms2023-071.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Девришов РД, Коломин ВВ, Филяев ВН, Кудряшева ИА. Гигиенические аспекты воздействия факторов среды обитания на формирование здоровья учащихся. Российский медико-биологический вестник им. академика И.П. Павлова. 2019;27(4):530–535. https://doi.org/10.23888/PAVLOVJ2019274530-535.</mixed-citation><mixed-citation xml:lang="en">Devrishov PD, Kolomin VV, Filyaev VN, Kudryasheva IA. Hygienic aspects of influence of environmental factors on formation of schoolchildren’s health. I.P. Pavlov Russian Medical Biological Herald. 2019;27(4):530–535. (In Russ.) https://doi.org/10.23888/PAVLOVJ2019274530-535.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Ivashkin VT, Sheptulin A, Shifrin O, Poluektova E, Pavlov C, Ivashkin K et al. Clinical validation of the “7 × 7” questionnaire for patients with functional gastrointestinal disorders. J Gastroenterol Hepatol. 2019;34(6):1042–1048. https://doi.org/10.1111/jgh.14546.</mixed-citation><mixed-citation xml:lang="en">Ivashkin VT, Sheptulin A, Shifrin O, Poluektova E, Pavlov C, Ivashkin K et al. Clinical validation of the “7 × 7” questionnaire for patients with functional gastrointestinal disorders. J Gastroenterol Hepatol. 2019;34(6):1042–1048. https://doi.org/10.1111/jgh.14546.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Barberio B, Mahadeva S, Black CJ, Savarino EV, Ford AC. Systematic review with meta-analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria. Aliment Pharmacol Ther. 2020;52(5):762–773. https://doi.org/10.1111/apt.16006.</mixed-citation><mixed-citation xml:lang="en">Barberio B, Mahadeva S, Black CJ, Savarino EV, Ford AC. Systematic review with meta-analysis: global prevalence of uninvestigated dyspepsia according to the Rome criteria. Aliment Pharmacol Ther. 2020;52(5):762–773. https://doi.org/10.1111/apt.16006.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Ford AC, Marwaha A, Sood R, Moayyedi P. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015;64(7):1049–1057. https://doi.org/10.1136/gutjnl-2014-307843.</mixed-citation><mixed-citation xml:lang="en">Ford AC, Marwaha A, Sood R, Moayyedi P. Global prevalence of, and risk factors for, uninvestigated dyspepsia: a meta-analysis. Gut. 2015;64(7):1049–1057. https://doi.org/10.1136/gutjnl-2014-307843.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Цуканов ВВ, Васютин АВ, Тонких ЮЛ. Распространенность, факторы риска и этнические особенности неисследованной диспепсии. РМЖ. Медицинское обозрение. 2020;4(5):263–267. https://doi.org/10.32364/2587-6821-2020-4-5-263-267.</mixed-citation><mixed-citation xml:lang="en">Tsukanov VV, Vasyutin AV, Tonkikh YuL. Prevalence, risk factors, and ethnic characteristics of uninvestigated dyspepsia. RMJ. Medical Review. 2020;4(5):264–267. (In Russ.) https://doi.org/10.32364/2587-6821-2020-4-5-263-267.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Arnaout AY, Alhejazi TJ, Nerabani Y, Hamdan O, Arnaout K, Arnaout I et al. The prevalence and risk factors of functional dyspepsia among adults in low- and middle-income countries: An international cross-sectional study. Medicine (Baltimore). 2023;102(40):e35437. https://doi.org/10.1097/MD.0000000000035437.</mixed-citation><mixed-citation xml:lang="en">Arnaout AY, Alhejazi TJ, Nerabani Y, Hamdan O, Arnaout K, Arnaout I et al. The prevalence and risk factors of functional dyspepsia among adults in low- and middle-income countries: An international cross-sectional study. Medicine (Baltimore). 2023;102(40):e35437. https://doi.org/10.1097/MD.0000000000035437.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Kim SE, Kim N, Lee JY, Park KS, Shin JE, Nam K et al. Prevalence and Risk Factors of Functional Dyspepsia in Health Check-up Population: A Nationwide Multicenter Prospective Study. J Neurogastroenterol Motil. 2018;24(4):603–613. https://doi.org/10.5056/jnm18068.</mixed-citation><mixed-citation xml:lang="en">Kim SE, Kim N, Lee JY, Park KS, Shin JE, Nam K et al. Prevalence and Risk Factors of Functional Dyspepsia in Health Check-up Population: A Nationwide Multicenter Prospective Study. J Neurogastroenterol Motil. 2018;24(4):603–613. https://doi.org/10.5056/jnm18068.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Bharucha AE, Sharma M. Painful and Painless Constipation: All Roads Lead to (A Change in) Rome. Dig Dis Sci. 2018;63(7):1671–1674. https://doi.org/10.1007/s10620-018-5027-2.</mixed-citation><mixed-citation xml:lang="en">Bharucha AE, Sharma M. Painful and Painless Constipation: All Roads Lead to (A Change in) Rome. Dig Dis Sci. 2018;63(7):1671–1674. https://doi.org/10.1007/s10620-018-5027-2.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Филиппов ЕВ, Заикина ЕВ, Никулина НН. Наличие клинически значимой тревоги и депрессии как новый фактор риска хронических неинфекционных заболеваний? Наука молодых (Eruditio Juvenium). 2019;7(1):28–37. https://doi.org/10.23888/HMJ20197128-37.</mixed-citation><mixed-citation xml:lang="en">Filippov EV, Zaikina EV, Nikylina NN. Is existence of clinically significant anxiety and depression a new risk factor for chronic non-infectious diseases? Science of the Young (Eruditio Juvenium). 2019;7(1):28–37. (In Russ.) https://doi.org/10.23888/HMJ20197128-37.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Zia JK, Lenhart A, Yang PL, Heitkemper MM, Baker J, Keefer L et al. Risk Factors for Abdominal Pain-Related Disorders of Gut-Brain Interaction in Adults and Children: A Systematic Review. Gastroenterology. 2022;163(4):995–1023.e3. https://doi.org/10.1053/j.gastro.2022.06.028.</mixed-citation><mixed-citation xml:lang="en">Zia JK, Lenhart A, Yang PL, Heitkemper MM, Baker J, Keefer L et al. Risk Factors for Abdominal Pain-Related Disorders of Gut-Brain Interaction in Adults and Children: A Systematic Review. Gastroenterology. 2022;163(4):995–1023.e3. https://doi.org/10.1053/j.gastro.2022.06.028.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Narayanan SP, Anderson B, Bharucha AE. Sex- and Gender-Related Differences in Common Functional Gastroenterologic Disorders. Mayo Clin Proc. 2021;96(4):1071–1089. https://doi.org/10.1016/j.mayocp.2020.10.004.</mixed-citation><mixed-citation xml:lang="en">Narayanan SP, Anderson B, Bharucha AE. Sex- and Gender-Related Differences in Common Functional Gastroenterologic Disorders. Mayo Clin Proc. 2021;96(4):1071–1089. https://doi.org/10.1016/j.mayocp.2020.10.004.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Zand Irani M, Jones MP, Halland M, Herrick L, Choung RS, Saito Loftus YA et al. Prevalence, symptoms and risk factor profile of rumination syndrome and functional dyspepsia: a population-based study. Aliment Pharmacol Ther. 2021;54(11-12):1416–1431. https://doi.org/10.1111/apt.16630.</mixed-citation><mixed-citation xml:lang="en">Zand Irani M, Jones MP, Halland M, Herrick L, Choung RS, Saito Loftus YA et al. Prevalence, symptoms and risk factor profile of rumination syndrome and functional dyspepsia: a population-based study. Aliment Pharmacol Ther. 2021;54(11-12):1416–1431. https://doi.org/10.1111/apt.16630.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Javed M, Yadav T, Shakil J, Haider Zaidi ST, Zehra M. Prevalence of irritable bowel syndrome and functional dyspepsia and their relationship with generalized anxiety disorder among medical students in Karachi. J Pak Med Assoc. 2022;72(10):2132–2136. https://doi.org/10.47391/JPMA.4927.</mixed-citation><mixed-citation xml:lang="en">Javed M, Yadav T, Shakil J, Haider Zaidi ST, Zehra M. Prevalence of irritable bowel syndrome and functional dyspepsia and their relationship with generalized anxiety disorder among medical students in Karachi. J Pak Med Assoc. 2022;72(10):2132–2136. https://doi.org/10.47391/JPMA.4927.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Beh KH, Chuah KH, Rappek NAM, Mahadeva S. The association of body mass index with functional dyspepsia is independent of psychological morbidity: A cross-sectional study. PLoS ONE. 2021;16(1):e0245511. https://doi.org/10.1371/journal.pone.0245511.</mixed-citation><mixed-citation xml:lang="en">Beh KH, Chuah KH, Rappek NAM, Mahadeva S. The association of body mass index with functional dyspepsia is independent of psychological morbidity: A cross-sectional study. PLoS ONE. 2021;16(1):e0245511. https://doi.org/10.1371/journal.pone.0245511.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Feinle-Bisset C. Upper gastrointestinal sensitivity to meal-related signals in adult humans – relevance to appetite regulation and gut symptoms in health, obesity and functional dyspepsia. Physiol Behav. 2016;162:69–82. https://doi.org/10.1016/j.physbeh.2016.03.021.</mixed-citation><mixed-citation xml:lang="en">Feinle-Bisset C. Upper gastrointestinal sensitivity to meal-related signals in adult humans – relevance to appetite regulation and gut symptoms in health, obesity and functional dyspepsia. Physiol Behav. 2016;162:69–82. https://doi.org/10.1016/j.physbeh.2016.03.021.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(10):908–917. https://doi.org/10.1016/S2468-1253(20)30217-X.</mixed-citation><mixed-citation xml:lang="en">Oka P, Parr H, Barberio B, Black CJ, Savarino EV, Ford AC. Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2020;5(10):908–917. https://doi.org/10.1016/S2468-1253(20)30217-X.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Accarie A, Toth J, Wauters L, Farré R, Tack J, Vanuytsel T. Estrogens Play a Critical Role in Stress-Related Gastrointestinal Dysfunction in a Spontaneous Model of Disorders of Gut-Brain Interaction. Cells. 2022;11(7):1214. https://doi.org/10.3390/cells11071214.</mixed-citation><mixed-citation xml:lang="en">Accarie A, Toth J, Wauters L, Farré R, Tack J, Vanuytsel T. Estrogens Play a Critical Role in Stress-Related Gastrointestinal Dysfunction in a Spontaneous Model of Disorders of Gut-Brain Interaction. Cells. 2022;11(7):1214. https://doi.org/10.3390/cells11071214.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Choi YJ, Park YS, Kim N, Kim YS, Lee SM, Lee DH, Jung HC. Gender differences in ghrelin, nociception genes, psychological factors and quality of life in functional dyspepsia. World J Gastroenterol. 2017;23(45):8053–8061. https://doi.org/10.3748/wjg.v23.i45.8053.</mixed-citation><mixed-citation xml:lang="en">Choi YJ, Park YS, Kim N, Kim YS, Lee SM, Lee DH, Jung HC. Gender differences in ghrelin, nociception genes, psychological factors and quality of life in functional dyspepsia. World J Gastroenterol. 2017;23(45):8053–8061. https://doi.org/10.3748/wjg.v23.i45.8053.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Маев ИВ, Охлобыстина ОЗ, Халиф ИЛ, Андреев ДН. Синдром раздраженного кишечника в Российской Федерации – результаты многоцентрового наблюдательного исследования ROMERUS. Терапевтический архив. 2023;95(1):38–51. https://doi.org/10.26442/00403660.2023.01.202043.</mixed-citation><mixed-citation xml:lang="en">Maev IV, Okhlobystina OZ, Khalif IL, Andreev DN. Irritable bowel syndrome in the Russian Federation: results of the ROMERUS multicenter observational study. Terapevticheskii Arkhiv. 2023;95(1):38–51. (In Russ.) https://doi.org/10.26442/00403660.2023.01.202043.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Yap PR, Goh KL. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Induced Dyspepsia. Curr Pharm Des. 2015;21(35):5073–5081. https://doi.org/10.2174/1381612821666150915105738.</mixed-citation><mixed-citation xml:lang="en">Yap PR, Goh KL. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Induced Dyspepsia. Curr Pharm Des. 2015;21(35):5073–5081. https://doi.org/10.2174/1381612821666150915105738.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Симаненков ВИ, Маев ИВ, Ткачева ОН, Алексеенко СА, Андреев ДН, Бордин ДС, и др. Синдром повышенной эпителиальной проницаемости в клинической практике. Мультидисциплинарный национальный консенсус. Кардиоваскулярная терапия и профилактика. 2021;20(1):2758. https://doi.org/10.15829/1728-8800-2021-2758.</mixed-citation><mixed-citation xml:lang="en">Simanenkov VI, Maev IV, Tkacheva ON, Alekseenko SA, Andreev DN, Bordin DS et al. Syndrome of increased epithelial permeability in clinical practice. Multidisciplinary national Consensus. Cardiovascular Therapy and Prevention. 2021;20(1):2758. (In Russ.) https://doi.org/10.15829/1728-8800-2021-2758.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">von Wulffen M, Talley NJ, Hammer J, McMaster J, Rich G, Shah A et al. Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors. Dig Dis Sci. 2019;64(2):480–486. https://doi.org/10.1007/s10620-018-5343-6.</mixed-citation><mixed-citation xml:lang="en">von Wulffen M, Talley NJ, Hammer J, McMaster J, Rich G, Shah A et al. Overlap of Irritable Bowel Syndrome and Functional Dyspepsia in the Clinical Setting: Prevalence and Risk Factors. Dig Dis Sci. 2019;64(2):480–486. https://doi.org/10.1007/s10620-018-5343-6.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
